/TCNNF

TCNNF Stock - Trulieve Cannabis Corp.

Q: What is the analyst price target for TCNNF?

Analyst price target information is not currently available for TCNNF.

Q: What is TCNNF's market cap?

Market capitalization information is not currently available for TCNNF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$8.73-3.22%

$0.29 (-3.22%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

High Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+440.8%upside

Target: $47.21

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TCNNF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.66

52W High$11.83

52W Low$3.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.19B	$1.13B	$1.24B	$938.38M	$521.53M
Gross Profit	$715.75M	$588.63M	$682.00M	$566.13M	$386.42M
Gross Margin	60.3%	52.1%	55.0%	60.3%	74.1%
Operating Income	$97.78M	$-221,613,000	$109.40M	$196.95M	$218.37M
Net Income	$-155,105,000	$-526,796,000	$-205,100,000	$18.03M	$63.00M
Net Margin	-13.1%	-46.7%	-16.5%	1.9%	12.1%
EPS	$-0.82	$-2.84	$-1.10	$0.13	$0.55

Company Overview

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.

Visit Website

Earnings History & Surprises

TCNNF

Beat Rate

22%

Last 18 quarters

Avg Surprise

-150.5%

EPS vs Estimate

Beats / Misses

4/14

Last 12 quarters

Latest EPS

$-0.14

Q4 2025

EPS Surprise History

Q1 24

-12.5%

$-0.18vs$-0.16

Q2 24

-20.0%

$-0.12vs$-0.10

Q3 24

+25.0%

$-0.06vs$-0.08

Q4 24

-153.8%

$-0.33vs$-0.13

Q1 25

-50.0%

$-0.27vs$-0.18

Q2 25

-112.5%

$-0.17vs$-0.08

Q3 25

-7.6%

$-0.07vs$-0.07

Q4 25

-383.8%

$-0.14vs$-0.03

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 5, 2026	—	—	—	—
Q1 2026	Feb 25, 2026	—	—	—	—
Q4 2025	Nov 5, 2025	$-0.03	$-0.14	-383.8%	✗ MISS
Q3 2025	Aug 6, 2025	$-0.07	$-0.07	-7.6%	✗ MISS
Q2 2025	May 7, 2025	$-0.08	$-0.17	-112.5%	✗ MISS
Q1 2025	Feb 26, 2025	$-0.18	$-0.27	-50.0%	✗ MISS
Q4 2024	Nov 5, 2024	$-0.13	$-0.33	-153.8%	✗ MISS
Q3 2024	Aug 6, 2024	$-0.08	$-0.06	+25.0%	✓ BEAT
Q2 2024	May 9, 2024	$-0.10	$-0.12	-20.0%	✗ MISS
Q1 2024	Feb 29, 2024	$-0.16	$-0.18	-12.5%	✗ MISS
Q4 2023	Nov 9, 2023	$-0.17	$-0.14	+17.6%	✓ BEAT
Q3 2023	Aug 9, 2023	$-0.19	$-0.51	-168.4%	✗ MISS
Q2 2023	May 10, 2023	$-0.16	$-0.34	-112.5%	✗ MISS
Q1 2023	Mar 8, 2023	$-0.11	$-0.41	-272.7%	✗ MISS
Q4 2022	Nov 9, 2022	$-0.05	$0.02	+140.0%	✓ BEAT
Q3 2022	Aug 10, 2022	$-0.02	$-0.12	-531.6%	✗ MISS
Q2 2022	May 12, 2022	$-0.02	$-0.17	-691.4%	✗ MISS
Q1 2022	Mar 30, 2022	$0.18	$-0.46	-355.6%	✗ MISS
Q4 2021	Nov 15, 2021	$0.24	$0.17	-29.2%	✗ MISS
Q3 2021	Aug 12, 2021	$0.28	$0.31	+10.7%	✓ BEAT

Frequently Asked Questions about TCNNF

What is TCNNF's current stock price?

Trulieve Cannabis Corp. (TCNNF) is currently trading at $8.73 per share. The stock has moved -3.22% today.

What is the analyst price target for TCNNF?

The average analyst price target for TCNNF is $47.21, based on 1 analyst.

What sector is Trulieve Cannabis Corp. in?

Trulieve Cannabis Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is TCNNF's market cap?

Trulieve Cannabis Corp. has a market capitalization of $1.67 billion, making it a small-cap company.

Does TCNNF pay dividends?

No, Trulieve Cannabis Corp. does not currently pay a dividend to shareholders.